Froptix is developing eye disease therapeutics.

History:

In mid-2007 Acuity Pharmaceuticals and Froptix went through a reverse merger with eXegenics to become Opko.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:

Research Focus:

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: